Search clinical trials for: LHRH analogues

Total 396 results

Ipsen

Completed

To Evaluate the Criteria for Renewal of Luteinizing Hormone-Releasing Hormone (LHRH) Analogue Treatment in Prostate Cancer Patients (ANAREN)

Prostate Cancer

Spain
University of Aarhus

Unknown

LH Response to GnRH Test in Prepubescent Girls Under 6 Years

Precocious Puberty

Denmark
King Abdullah International Medical Research Center
Hoffmann-La Roche

Unknown

To Study the Effect of Adding on Pegylated Interferon (PEG-INF) Therapy for Patients Diagnosed With Chronic Hepatitis B (RC14/055)

Hepatitis B

Saudi Arabia
St Vincent's Hospital Melbourne
National Health and Medical Research Council, Australia

Unknown

Determinants of Virological Response After Discontinuation of Nucleoside Analogue Therapy in Hepatitis B Patients (STOP)

Chronic Hepatitis B.

Australia
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Completed

Two Rebeccamycin Analogue Regimens in Treating Patients With Advanced or Recurrent Non-small Cell Lung Cancer

Lung Cancer

United States
Groupe Hospitalier Paris Saint Joseph

Recruiting

Interest of GLP1 Analogues in Overweight Type 2 Diabetic Patients With Chronic Inflammatory Bowel Disease (DiagMICI)

Diabetes Mellitus, Type 2 | Inflammatory Bowel Diseases

France
National Cancer Institute (NCI)

Terminated

Rebeccamycin Analog as Second-Line Therapy in Treating Patients With Limited-Stage or Extensive-Stage Small Cell Lung Cancer That Relapsed After Previous First-Line Chemotherapy

Extensive Stage Small Cell Lung Cancer | Recurrent Small Cell Lung Cancer | Limited Stage Small Cell Lung Cancer

United States
Eli Lilly and Company
Bayer

Active, not recruiting

Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment

Prostatic Neoplasms

Spain, Germany, United States
Noah Hahn, M.D.
Bristol-Myers Squibb

Terminated

Neoadjuvant Dasatinib Plus LHRH Analogue Therapy in High-Risk Localized Prostate Cancer

Prostate Cancer

United States
Nicola Frei

Not yet recruiting

Evaluation of Post-ERCP Pain as a Predictor for Post-ERCP Pancreatitis (PEP-PREPARE)

Post-ERCP Acute Pancreatitis

Switzerland
University Magna Graecia

Completed

CA 125 and VAS Pain Score Changes to Diagnose Endometriosis

Endometriosis | Pelvic Pain

Italy
Progen Pharmaceuticals
National Cancer Institute (NCI)

Completed

SL-11047 in Treating Patients With Relapsed or Refractory Lymphoma

Lymphoma

United States
Case Comprehensive Cancer Center
National Cancer Institute (NCI)

Terminated

Rebeccamycin Analogue in Treating Patients With Advanced Liver and/or Biliary Cancer

Liver Cancer | Gallbladder Cancer | Extrahepatic Bile Duct Cancer

United States
University Hospital, Ioannina
OTORHINOLARYNGOLOGY DEPARTMENT, UNIVERSITY GENERAL HOSPITAL OF IOANNINA; 1st...

Completed

EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY

Olfactory and Taste Dysfunction in SARS-CoV2 Infection

Greece
GlyPharma Therapeutics
VectivBio AG

Completed

Metabolic Balance Study of FE203799 in Patients With SBS With Intestinal Insufficiency

SBS - Short Bowel Syndrome

Denmark
National Cancer Institute (NCI)

Completed

Rebeccamycin Analogue in Treating Women With Stage IIIB or Stage IV Breast Cancer

Male Breast Cancer | Stage IV Breast Cancer | Stage IIIB Breast Cancer | Recurrent Breast Cancer

United States
National Cancer Institute (NCI)

Completed

Rebeccamycin Analog in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphoblastic Leukemia, or Chronic Myelogenous Leukemia

Chronic Myelomonocytic Leukemia | Recurrent Adult Acute Myeloid Leukemia | Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities | Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) | Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) | Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) and other conditions

United States
Ferring Pharmaceuticals

Completed

Therapy Pathways in the Treatment of Hormone Naïve Prostate Cancer Patients With and Without Comorbidities Treated With Degarelix or Luteinizing-Hormone-Releasing-Hormone (LHRH) Agonists. (ProComD)

Advanced Prostate Cancer

Germany
Alexandria University

Recruiting

Effect of Protein Restriction Plus EAA/KA Supplementation on GFR Decline in CKD

Chronic Kidney Diseases

Egypt
Oklahoma State University

Recruiting

Longitudinal Examination of Metabolic and Behavioral Correlates of Protein Sources

Health Behavior

United States
Universitair Ziekenhuis Brussel

Not yet recruiting

Translation and Implementation of the Dutch VVAS Score in Clinical Practice

Vertigo
Qingdao University
Qingdao Hiser Medical Group

Recruiting

Study of Hydrogen Inhalation Compared With Placebo in Type 2 Diabetes Patients

Type 2 Diabetes

China
Centre of Experimental Medicine
Millennium Pharmaceuticals, Inc.

Terminated

A Study of Neoadjuvant TAK-700 and Leuprorelin Acetate Followed by Surgery Versus Surgery Alone (NEPTUNE)

Prostate Cancer

United Kingdom
European Organisation for Research and Treatment...

Completed

Early Compared With Delayed Hormone Therapy in Treating Patients With Nonmetastatic Prostate Cancer

Neoplasm, Prostate
Sun Yat-sen University

Not yet recruiting

A Prospective Observational Study About Adjuvant or Neoadjuvant Chemotherapy Related Adverse Effects in Premenopausal Breast Cancer Patients

Breast Cancer

China
Istanbul Medipol University Hospital

Completed

Comparison of Different Pain Rating Scales in Patients With Symptomatic Teeth (CoPRS)

Pain | Dental Pain

Turkey
Rabin Medical Center
Ferring Pharmaceuticals

Completed

Endothelial Function in Prostate Cancer Patients on Degarelix vs. Luteinizing Hormone-Releasing Hormone Agonists

Cardiovascular Diseases | Prostatic Neoplasms

Israel
Allergan

Completed

An Observational Study of Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) Who Switched IOP-lowering Treatments

Ocular Hypertension | Glaucoma, Open-Angle

Turkey
University of British Columbia
British Columbia Children's Hospital; Providence Health & Services

Completed

Evaluation of Smartphone Versions of VAS and NRS for Use in Adults (Panda)

Postoperative Pain

Canada
Mahidol University

Completed

Steatohepatitis in Chronic Hepatitis B

Fatty Liver | Chronic Hepatitis b

Thailand
Arbutus Biopharma Corporation

Terminated

Safety, Tolerability, and Pharmacokinetics of AB-836 in Healthy Subjects and Subjects With Chronic HBV Infection

Chronic Hepatitis

Korea, Republic of, Hong Kong, Thailand, Canada, Australia, Moldova, Republic of, New Zealand, Ukraine
M.D. Anderson Cancer Center
Pfizer

Active, not recruiting

Sunitinib Malate With Hormonal Ablation for Patients Who Will Have Prostatectomy

Prostate Cancer

United States
Arbutus Biopharma Corporation

Recruiting

Safety, Tolerability, PK & PD of AB-101 Following Oral Administration in Healthy and CHB Subjects.

Chronic Hepatitis b

New Zealand
Vanderbilt University

Completed

Improving Hospitalizations for Children With ASD

Autism Spectrum Disorder | Autistic Disorder

United States
University of Houston

Recruiting

Ethnic Microaggressions and Smoking Behaviors Among Latinx Adults

Smoking | Discrimination, Racial

United States
Hospital de Clinicas de Porto Alegre

Unknown

Evaluation of Granulosa Cells Function After IVF Protocols

Infertility | In Vitro Fertilization Protocols

Brazil
Third Affiliated Hospital, Sun Yat-Sen University
Peking University; First People's Hospital of Foshan; Shenzhen Third People's...

Unknown

The Optimizing Treatment of PegIFN Alfa in HBeAg-negative CHB Patients With Low Level HBsAg

Chronic Hepatitis B

China
Medical University Innsbruck
Novartis

Completed

68Ga-DOTA-MGS5 PET/CT in Patients With Advanced Neuroendocrine Tumours

Neuroendocrine Tumors

Austria
Region Skane

Recruiting

Targeted Health Dialogues in Primary Care

Cardiovascular Diseases | Cancer | Risk Factors | Health Behaviors | Serious Diseases

Sweden
Australasian Gastro-Intestinal Trials Group
Canadian Cancer Trials Group

Not yet recruiting

Cessation of Somatostatin Analogues After PRRT in Mid-Gut Neuroendocrine Tumours (STOPNET)

Neuroendocrine Tumors

Australia
Hospices Civils de Lyon

Recruiting

Impact of Low Protein Diet Supplemented With Ketoanalogues Supplementation on Uremic Toxins Production (KETO-GUT)

Renal Failure

France
University Magna Graecia

Completed

AMH Levels Change During Treatment With GnRh Agonist

Endometriosis | Pelvic Pain | Uterine Fibroids | Endometriosis of Uterus

Italy
Merck KGaA, Darmstadt, Germany

Completed

Comparative Validation of the Growth Hormone Releasing Hormone and Arginine Test for the Diagnosis of Adult Growth Hormone Deficiency

Growth Hormone Deficiency

France
University of Washington
National Institute of Mental Health (NIMH)

Completed

Growth Hormone Releasing Hormone (GHRH) Treatment for Age-Related Sleep Disturbances

Sleep Disorders
Foundation for Liver Research

Completed

PEG-IFN in HBV Patients With Incomplete Response to NA (PADD)

Chronic Hepatitis B

Netherlands
Beijing Ditan Hospital

Unknown

Cohort Study of Clinical Outcomes in Chronic HBV Infection Patients With Low HBsAg Under Unplanned Intervention

Chronic Hepatitis B Infection

China
M.D. Anderson Cancer Center
Abbott

Completed

Study of ABT-510 (Thrombospondin Analogue) in Patients With Advanced Head and Neck Cancer

Head and Neck Cancer

United States
Northwestern University
Abbott

Completed

SNAP: Switching Nucleoside Analogues Protocol - Lipoatrophy and Mitochondrial Function

HIV Infection

United States
Qing XIe

Recruiting

A Prospective Study to Evaluate Peginterferon in Reducing the Incidence of HCC in CHB Patients

Chronic Hepatitis B | Intermediate to High Risk of HCC

China
Fuda Cancer Hospital, Guangzhou
Shanghai Asclepius Meditech Co., Ltd

Completed

Hydrogen Gas for Cancer Rehabilitation

Adult Solid Tumor

China

Search clinical trials for: LHRH analogues

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations